Our results indicate that exosomal lncRNA PITPNA-AS1 is a promising biomarker for lung cancer diagnosis, and it may contribute to developing prognostic tools and therapeutic strategies for lung cancer. This evidence concerns the gene PITPNA and lung cancer.